X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Plasma Protease C1-inhibitorCompanies

This report lists the top Plasma Protease C1-inhibitor companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Plasma Protease C1-inhibitor industry.

Plasma Protease C1-inhibitorTop Companies

  1. CSL Behring

  2. Takeda Pharmaceuticals

  3. Pharming Technologies B.V.

  4. KalVista Pharmaceuticals

  5. BioCryst Pharmaceuticals

*Disclaimer: Top companies sorted in no particular order

 Plasma Protease C1-inhibitor Market Major Players

Plasma Protease C1-inhibitorMarket Concentration

Plasma Protease C1-inhibitorMarket Concentration

Plasma Protease C1-inhibitorCompany List

  • CSL Limited (CSL Behring LLC)

  • Ionis Pharmaceuticals, Inc.

  • Pharming Technologies B.V.

  • Centogene AG

  • BioCryst Pharmaceuticals

  • KalVista Pharmaceuticals, Inc.

  • Fresenius Kabi


Specific to Plasma Protease C1-inhibitor Market
Need More Details On Market Players And Competitors?
Download PDF

Plasma Protease C1-inhibitor Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)